Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

Vitamins are essential nutrients your body needs to function optimally, supporting everything from immune health to energy metabolism. Understanding their roles and sources can empower you to prevent ...